These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35480992)

  • 21. A new player in chronic kidney disease mineral and bone disorder: tenascin-C.
    Ozkan G; Ulusoy S; Guvercin B; Menteşe A; Karahan SC; Yavuz A
    Int J Artif Organs; 2015 Sep; 38(9):481-7. PubMed ID: 26449567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Analysis of Vascular Calcification Risk Factors in Pre-Hemodialysis and Prevalent Hemodialysis Adult Patients: Insights into Calcification Biomarker Associations and Implications for Intervention Strategies in Chronic Kidney Disease.
    Petrović M; Brković V; Baralić M; Marić I; Petković N; Stanković S; Lalić N; Stanisavljević D; Đukanović L; Ležaić V
    Diagnostics (Basel); 2024 Apr; 14(8):. PubMed ID: 38667470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum fibroblast growth factor 23 (FGF-23): associations with hyperphosphatemia and clinical staging of feline chronic kidney disease.
    Lin J; Lin L; Chen S; Yu L; Chen S; Xia Z
    J Vet Diagn Invest; 2021 Mar; 33(2):288-293. PubMed ID: 33543676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular calcification relationship to vascular biomarkers and bone metabolism in advanced chronic kidney disease.
    Salam S; Gallagher O; Gossiel F; Paggiosi M; Eastell R; Khwaja A
    Bone; 2021 Feb; 143():115699. PubMed ID: 33091638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trabecular bone score may indicate chronic kidney disease-mineral and bone disorder (CKD-MBD) phenotypes in hemodialysis patients: a prospective observational study.
    Yun HJ; Ryoo SR; Kim JE; Choi YJ; Park I; Shin GT; Kim H; Jeong JC
    BMC Nephrol; 2020 Jul; 21(1):299. PubMed ID: 32711466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients.
    Turan MN; Kircelli F; Yaprak M; Sisman AR; Gungor O; Bayraktaroglu S; Ozkahya M; Asci G; Floege J; Ok E
    Int Urol Nephrol; 2016 Apr; 48(4):609-17. PubMed ID: 26865177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic hemodialysis patients without marked elevation of intact parathyroid hormone are also good candidates for early intervention with cinacalcet.
    Nishida H; Masakane I; Kudo K; Ito M; Tanida H; Koshika M; Nishida W; Tomita Y
    Ther Apher Dial; 2013 Jun; 17(3):325-31. PubMed ID: 23735149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor 23 (FGF23) level is associated with ultrafiltration rate in patients on hemodialysis.
    Nishizawa Y; Hosoda Y; Horimoto A; Omae K; Ito K; Higuchi C; Sakura H; Nitta K; Ogawa T
    Heart Vessels; 2021 Mar; 36(3):414-423. PubMed ID: 33000285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Circulating bone turnover markers and their relationships in hemodialysis patients with vitamin D deficiency].
    Kulicki P; Żebrowski P; Sokalski A; Klatko W; Birecka M; Mieczkowski M; Niemczyk S; Małyszko J; Matuszkiewicz-Rowińska J
    Wiad Lek; 2019; 72(11 cz 2):2202-2209. PubMed ID: 31860837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher serum trimethylamine-N-oxide levels are associated with increased abdominal aortic calcification in hemodialysis patients.
    He L; Yang W; Yang P; Zhang X; Zhang A
    Ren Fail; 2022 Dec; 44(1):2019-2027. PubMed ID: 36384389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease.
    Manghat P; Fraser WD; Wierzbicki AS; Fogelman I; Goldsmith DJ; Hampson G
    Osteoporos Int; 2010 Nov; 21(11):1853-61. PubMed ID: 20012018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study.
    Fox CS; Larson MG; Vasan RS; Guo CY; Parise H; Levy D; Leip EP; O'donnell CJ; D'Agostino RB; Benjamin EJ
    J Am Soc Nephrol; 2006 Feb; 17(2):521-7. PubMed ID: 16382018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor 23 and left ventricular mass index in maintenance hemodialysis patients: standard versus long nocturnal hemodialysis.
    Knap B; Večerić-Haler Ž; Benedik M; Buturović-Ponikvar J; Ponikvar R; Bren AF
    Ther Apher Dial; 2013 Aug; 17(4):407-11. PubMed ID: 23931880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Relation Between Variability of Intact Parathyroid Hormone, Calcium, and Cardiac Mortality in Hemodialysis Patients.
    Ulusoy S; Ozkan G; Guvercin B; Yavuz A
    Artif Organs; 2016 Nov; 40(11):1078-1085. PubMed ID: 27110947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profile of incident chronic kidney disease related-mineral bone disorders in chronic kidney disease Stage 4 and 5: A hospital based cross-sectional survey.
    Valson AT; Sundaram M; David VG; Deborah MN; Varughese S; Basu G; Mohapatra A; Alexander S; Jose J; Roshan J; Simon B; Rebekah G; Tamilarasi V; Jacob CK
    Indian J Nephrol; 2014 Mar; 24(2):97-107. PubMed ID: 24701042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mineral and bone disorder biomarkers and inflammation indexes in patients with end stage renal disease.
    Zhang L; Yu Q; Chen X; Zhang M; He Y; Ji Z; Chen R; Zhang J; Zhang H; Shi G; Huang J
    Ann Palliat Med; 2020 Nov; 9(6):3938-3946. PubMed ID: 33302656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of FGF-23 measurement in dialysis patients.
    Jongbloed F; Galassi A; Cozzolino M; Zietse R; Chiarelli G; Cusi D; Brancaccio D; Gallieni M
    Clin Nephrol; 2011 Sep; 76(3):201-9. PubMed ID: 21888857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis.
    Nagata Y; Inaba M; Imanishi Y; Okazaki H; Yamada S; Mori K; Shoji S; Koyama H; Okuno S
    Osteoporos Int; 2015 Mar; 26(3):1053-61. PubMed ID: 25403902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast Growth Factor-23 in Pre-Dialysis Chronic Kidney Disease Patients and its Correlation with Carotid Artery Calcification.
    Kumar T; Mohanty S; Rani A; Malik A; Kumar R; Bhashker G
    Indian J Nephrol; 2022; 32(6):560-566. PubMed ID: 36704592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistently low intact parathyroid hormone levels predict a progression of aortic arch calcification in incident hemodialysis patients.
    Rhee H; Song SH; Kwak IS; Lee SB; Lee DW; Seong EY; Kim IY
    Clin Exp Nephrol; 2012 Jun; 16(3):433-41. PubMed ID: 22218932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.